3 ms·
Perhaps, but it is also true that these targeted therapies have different success rates among different cancers. Vemurafenib, famously approved for melanoma, ha
by niels_olson 11y ago
Perhaps, but it is also true that these targeted therapies have different success rates among different cancers. Vemurafenib, famously approved for melanoma, hasn't been as successful in papillary thyroid.